GLOBUS MEDICAL INC - A (GMED)
US3795772082 - Common Stock
Interesting GMED Put And Call Options For December 20th
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical Schedules First Quarter Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
Globus Medical Breaks Above 200-Day Moving Average - Bullish for GMED
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
With automated machines set to integrate into everyday functionalities, these are the robotics stocks that could make you rich.
Globus Medical (GMED) Shares Cross Below 200 DMA
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.
Globus Medical Larger Than S&P 500 Component BorgWarner
Globus Medical (GMED) Q4 2023 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2023.
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023.
First Week of GMED April 19th Options Trading
Bullish Two Hundred Day Moving Average Cross - GMED
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth...
Do Investors Have Too Much Money Out of the Market?
We've also got a look at two stocks worth watching: Globus Medical and RPM International.
GMED Crosses Below Key Moving Average Level
First Week of GMED September 20th Options Trading
7 Healthcare Stocks Taking Medicine to the Next Level
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Globus Medical expects Q4 sales of about $615.5M (NYSE:GMED)
Globus Medical expects an impressive increase in sales for Q4 2023 and projects a promising revenue guidance range for 2024.
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022 on an as-reported basis. Full year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2 percent over the prior year on an as-reported basis.
First Week of GMED February 2024 Options Trading